{
  "author": {
    "name": "John D Jones",
    "webUrl": "/author/profile/john-d-jones/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 1,
    "social": [],
    "articles": [
      {
        "uri": "/2017/04/26/fault-for-high-priced-drugs-lies-with-drug-makers/",
        "title": "Fault for high-priced drugs lies with drug makers",
        "byline": "John D Jones",
        "kicker": "",
        "prettyDate": "April 26, 2017",
        "timeToRead": "3 minute",
        "image": {
          "uri": "",
          "width": "",
          "height": ""
        },
        "authors": [
          {
            "webUrl": "/author/profile/john-d-jones/",
            "name": "John D Jones"
          }
        ],
        "kickerNode": [],
        "summary": "Instead of simply acknowledging their pricing strategies, drug companies and their lobbyists have launched a finger pointing campaign at pharmacy benefit managers (PBMs).",
        "body": null
      }
    ]
  }
}